Firstly, I don't consider MXC and MMJ to be comparing apples...

Firstly, I don't consider MXC and MMJ to be comparing apples with apples. Not saying one is better than the other, just not the same beast and completely different agendas.

I'll be honest, I've only looked into AC8 on a superficial level so was asking what all the fuss is about seeing as though @37337 raised it in an MXC thread. I don't want to go into the AC8 thread and be labelled a downramper because I don't understand their business model.

From what I can see -

51.8 million approx market cap based on 24c after consolidation.

28 million performance shares due to hit the market almost immediately.

Deal to grow in Chile due Q1 2017 which enacts performance milestone.

For me and in my opinion etc. I just can't justify how they are better placed than MXC who is currently valued at 34 million.

Please correct me if I'm wrong. I've only had a brief look into them as I thought they might be worth a punt but at this stage I think I'll pass.